BOARD OF DIRECTORS

As a QHP Operating Advisor, Mike offers over 35 years of experience in the pharmaceutical, biologics, and medical device industries, with a focus on product development and regulatory sciences. He has worked on numerous approved NDAs, ANDA, and MAAs. Mike’s company, Beckloff Associates, a preeminent global consulting group, employed over 100 pharmaceutical and regulatory scientists, providing service to over 200 clients worldwide. Cardinal Health acquired Beckloff Associates in 2004, where Mike continued until co-founding Silvergate Pharmaceuticals. Mike was the Chief Development Officer at Silvergate, then Azurity Pharmaceuticals for another decade after its acquisition of Silvergate in 2010.

Mike received his Cellular Biology Degree from the University of Kansas.